Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Electroconvulsive Therapy
NCT00045916Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2001
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nortriptyline, venlafaxine in major depressive disorder (MDD), bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Started Feb 2001; status: completed.
02
Drugs
nortriptylinevenlafaxine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00045916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045916.